Thriva
Seedtable Score
44
Startups
1
Funding Rounds
2
Investors
$7.49m
Money raised
Overview
Thriva offers a convenient solution for health-conscious individuals through at-home finger-prick blood tests. Based in London and operating with a direct-to-consumer model, Thriva eliminates the need for clinic or lab visits. This allows users to monitor their health easily from home, enhancing convenience and supporting early detection of health issues. Backed by investors like Target Global and Pembroke VCT, Thriva is well-positioned for growth. The market is ripe for innovations in health tech, with increasing consumer demand for accessible and personalized health solutions.
- Website: https://thriva.co
- Business model: b2c
- Company size: 101 - 251 employees
- Headquarters: London, UK
- Social accounts: Twitter Linkedin
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
Investors (2)
Funding
Funding series
Funding Series Analysis
The company Thriva has raised a total of $7.49m in funding over 1 rounds.
Key Insights:
- Series A: $7.49m
Thriva Series A (2019, $7M)
$7.49m